Engineered Tr1 cells designed for clinical use can eliminate primary pediatric AML blasts
Ontology highlight
ABSTRACT: Engineered Tr1 cells designed for clinical use can eliminate primary pediatric AML blasts
PROVIDER: PRJNA591564 | ENA |
REPOSITORIES: ENA
ACCESS DATA